Oxidative stress and microglial cells in Parkinson's disease

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Peterson, Lynda J ^a   Flood, Patrick M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA SYNUCLEIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DEXAMETHASONE; DEXTROMETHORPHAN; DIPHENYLIODONIUM SALT; DJ 1 PROTEIN; I KAPPA B; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINAN DERIVATIVE; PARKIN; PROTEIN P47; PROTEIN P67; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 10; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONFORMATIONAL TRANSITION; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; HUMAN; MICROGLIA; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; ARTICLE; BIOLOGICAL MODEL; DISEASE MODEL; INFLAMMATION; METABOLISM; NERVE CELL; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION; MICROGLIA; MODELS, BIOLOGICAL; NADPH OXIDASE; NEURONS; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARKINSON DISEASE; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84861052006     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/401264     Document Type: Review

References (130)

1. Jellinger K. A., The pathology of Parkinson's disease Advances in Neurology 2001 86 55 72
2. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L., Mutation in the -synuclein gene identified in families with Parkinson's disease Science 1997 276 5321 2045 2047 (Pubitemid 27443610)
3. Sun M., Latourelle J. C., Wooten G. F., Lew M. F., Klein C., Shill H. A., Golbe L. I., Mark M. H., Racette B. A., Perlmutter J. S., Parsian A., Guttman M., Nicholson G., Xu G., Wilk J. B., Saint-Hilaire M. H., DeStefano A. L., Prakash R., Williamson S., Suchowersky O., Labelle N., Growdon J. H., Singer C., Watts R. L., Goldwurm S., Pezzoli G., Baker K. B., Pramstaller P. P., Burn D. J., Chinnery P. F., Sherman S., Vieregge P., Litvan I., Gillis T., MacDonald M. E., Myers R. H., Gusella J. F., Influence of heterozygosity for Parkin mutation on onset age in familial parkinson disease: the genePD study Archives of Neurology 2006 63 6 826 832 (Pubitemid 43882289)
4. Bonifati V., Wu-Chou Y. H., Schweiger D., Di Fonzo A., Lu C. S., Oostra B., LRRK2 mutation analysis in parkinson disease families with evidence of linkage to PARK8 Neurology 2008 70 24 2348 2349
5. Weng Y. H., Chou Y. H. W., Wu W. S., Lin K. J., Chang H. C., Yen T. C., Chen R. S., Wey S. P., Lu C. S., PINK1 mutation in Taiwanese early-onset parkinsonism: clinical, genetic, and dopamine transporter studies Journal of Neurology 2007 254 10 1347 1355
6. Abou-Sleiman P. M., Healy D. G., Quinn N., Lees A. J., Wood N. W., The role of pathogenic DJ-1 mutations in Parkinson's disease Annals of Neurology 2003 54 3 283 286 (Pubitemid 37072030)
7. Goldberg M. S., Pisani A., Haburcak M., Vortherms T. A., Kitada T., Costa C., Tong Y., Martella G., Tscherter A., Martins A., Bernardi G., Roth B. L., Pothos E. N., Calabresi P., Shen J., Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1 Neuron 2005 45 4 489 496 (Pubitemid 40249861)
8. Alam M., Schmidt W. J., Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats Behavioural Brain Research 2002 136 1 317 324 (Pubitemid 35246417)
9. Ebert A. D., Hoo J. H., Bohn M. C., Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3 Journal of Neuroscience Research 2008 86 2 317 325 (Pubitemid 351196737)
10. Meissner W., Prunier C., Guilloteau D., Chalon S., Gross C. E., Bezard E., Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease Molecular Neurobiology 2003 28 3 209 218 (Pubitemid 38156419)
11. Hirsch E. C., Hunot S., Hartmann A., Neuroinflammatory processes in Parkinson's disease Parkinsonism and Related Disorders 2005 11 supplement 1 S9 S15
12. Mosley R. L., Benner E. J., Kadiu I., Neuroinflammation, oxidative stres and the pathogenesis of Parkinson's disease Clinical Neurosicence Research 2006 6 5 261 281 (Pubitemid 44849177)
13. Bartels A. L., Leenders K. L., Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET Movement Disorders 2007 22 13 1852 1856 (Pubitemid 350134195)
14. Van Den Eeden S. K., Tanner C. M., Bernstein A. L., Fross R. D., Leimpeter A., Bloch D. A., Nelson L. M., Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity American Journal of Epidemiology 2003 157 11 1015 1022 (Pubitemid 36628805)
15. Baik J. H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E., Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors Nature 1995 377 6548 424 428
16. Wang Y., Xu R., Sasaoka T., Tonegawa S., Kung M. P., Sankoorikal E. B., Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions Journal of Neuroscience 2000 20 22 8305 8314
17. Fowler S. C., Zarcone T. J., Vorontsova E., Chen R., Motor and associative deficits in D2 dopamine receptor knockout mice International Journal of Developmental Neuroscience 2002 20 35 309 321
18. Jenner P., Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease Current Opinion in Neurology 2003 16 supplement 1 S3 S7
19. Liu B., Hong J. S., Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention Journal of Pharmacology and Experimental Therapeutics 2003 304 1 1 7 (Pubitemid 36008905)
20. Nelson P. T., Soma L. A., Lavi E., Microglia in diseases of the central nervous system Annals of Medicine 2002 34 7-8 491 500 (Pubitemid 36113806)
21. Guillemin G. J., Brew B. J., Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification Journal of Leukocyte Biology 2004 75 3 388 397 (Pubitemid 38316367)
22. Dauer W., Przedborski S., Parkinson's disease: mechanisms and models Neuron 2003 39 6 889 909 (Pubitemid 37130207)
23. Gao H. M., Kotzbauer P. T., Uryu K., Leight S., Trojanowski J. Q., Lee V. M. Y., Neuroinflammation and oxidation/nitration of -synuclein linked to dopaminergic neurodegeneration Journal of Neuroscience 2008 28 30 7687 7698
24. Block M. L., Hong J. S., Chronic microglial activation and progressive dopaminergic neurotoxicity Biochemical Society Transactions 2007 35 5 1127 1132 (Pubitemid 350206444)
25. Czonkowska A., Kohutnicka M., Kurkowska-Jastrzbska I., Czonkowski A., Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model Neurodegeneration 1996 5 2 137 143 (Pubitemid 26248603)
26. Kim W. G., Mohney R. P., Wilson B., Jeohn G. H., Liu B., Hong J. S., Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia Journal of Neuroscience 2000 20 16 6309 6316 (Pubitemid 30658427)
27. Ghosh A., Roy A., Liu X., Kordower J. H., Mufson E. J., Hartley D. M., Ghosh S., Mosley R. L., Gendelman H. E., Pahan K., Selective inhibition of NF- B activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18754 18759 (Pubitemid 350210769)
28. Cicchetti F., Brownell A. L., Williams K., Chen Y. I., Livni E., Isacson O., Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging European Journal of Neuroscience 2002 15 6 991 998 (Pubitemid 35463634)
29. McGeer P. L., Itagaki S., Boyes B. E., McGeer E. G., Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 1988 38 8 1285 1291
30. Nagatsu T., Mogi M., Ichinose H., Togari A., Changes in cytokines and neurotrophins in Parkinson's disease Journal of Neural Transmission, Supplement 2000 60 277 290 (Pubitemid 32037200)
31. Mogi M., Harada M., Kondob T., Riederer P., Inagaki H., Minami M., Nagatsu T., Interleukin-1, interleukin-6, epidermal growth factor and transforming growth factor- are elevated in the brain from parkinsonian patients Neuroscience Letters 1994 180 2 147 150
32. Bessler H., Djaldetti R., Salman H., Bergman M., Djaldetti M., IL-1, IL-2, IL-6 and TNF- production by peripheral blood mononuclear cells from patients with Parkinson's disease Biomedicine and Pharmacotherapy 1999 53 3 141 145 (Pubitemid 29507876)
33. Qureshi G. A., Baig S., Bednar I., Sodersten P., Forsberg G., Siden A., Increased cerebrospinal fluid concentration of nitrite ire Parkinson's disease NeuroReport 1995 6 12 1642 1644
34. Hunot S., Boissire F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., Hirsch E. C., Nitric oxide synthase and neuronal vulnerability in Parkinson's disease Neuroscience 1996 72 2 355 363 (Pubitemid 26111202)
35. Nagatsu T., Mogi M., Ichinose H., Togari A., Cytokines in Parkinson's disease Journal of Neural Transmission, Supplement 2000 58 143 151
36. Lull M. E., Block M. L., Microglial activation and chronic neurodegeneration Neurotherapeutics 2010 7 4 354 365
37. Liu B., Gao H. M., Wang J. Y., Jeohn G. H., Cooper C. L., Hong J. S., Role of nitric oxide in inflammation-mediated neurodegeneration Annals of the New York Academy of Sciences 2002 962 318 331 (Pubitemid 34592321)
38. Shukla V., Mishra S. K., Pant H. C., Oxidative stress in neurodegeneration Advances in Pharmacological Sciences 2011 2011 13
39. Kraft A. D., Jean Harry G., Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity International Journal of Environmental Research and Public Health 2011 8 7 2980 3018
40. Hanisch U. K., Microglia as a source and target of cytokines GLIA 2002 40 2 140 155
41. Heese K., Hock C., Otten U., Inflammatory signals induce neurotrophin expression in human microglial cells Journal of Neurochemistry 1998 70 2 699 707 (Pubitemid 28079359)
42. Whitney N. P., Eidem T. M., Peng H., Huang Y., Zheng J. C., Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders Journal of Neurochemistry 2009 108 6 1343 1359
43. Heese K., Fiebich B. L., Bauer J., Otten U., NF- B modulates lipopolysaccharide-induced microglial nerve growth factor expression GLIA 1998 22 4 401 407 (Pubitemid 28129717)
44. Yoneyama M., Shiba T., Hasebe S., Ogita K., Adult neurogenesis is regulated by endogenous factors produced during neurodegeneration Journal of Pharmacological Sciences 2011 115 4 425 432
45. Bronstein D. M., Perez-Otano I., Sun V., Mullis Sawin S. B., Chan J., Wu G. C., Hudson P. M., Kong L. Y., Hong J. S., McMillian M. K., Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures Brain Research 1995 704 1 112 116
46. Araki E., Forster C., Dubinsky J. M., Ross M. E., Iadecola C., Cyclooxygenase-2 inhibitor NS-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity Stroke 2001 32 10 2370 2375 (Pubitemid 32954810)
47. Zhang W., Wang T., Pei Z., Miller D. S., Wu X., Block M. L., Wilson B., Zhang W., Zhou Y., Hong J. S., Zhang J., Aggregated -synuclein activates microglia: a process leading to disease progression in Parkinson's disease The FASEB Journal 2005 19 6 533 542 (Pubitemid 40471244)
48. Itzhak Y., Martin J. L., Ali S. F., Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice Synapse 1999 34 4 305 312 (Pubitemid 29523136)
49. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., Mcauliffe W. G., Dawson V. L., Dawson T. M., Przedborski S., Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nature Medicine 1999 5 12 1403 1409
50. Dehmer T., Lindenau J., Haid S., Dichgans J., Schulz J. B., Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo Journal of Neurochemistry 2000 74 5 2213 2216 (Pubitemid 30217680)
51. Du Y., Ma Z., Lin S., Dodel R. C., Gao F., Bales K. R., Triarhou L. C., Chernet E., Perry K. W., Nelson D. L. G., Luecke S., Phebus L. A., Bymaster F. P., Paul S. M., Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2001 98 25 14669 14674 (Pubitemid 33121449)
52. Factor S. A., Sanchez-Ramos J., Weiner W. J., Trauma as an etiology of parkinsonism: a historical review of the concept Movement Disorders 1988 3 1 30 36
53. Ling Z., Gayle D. A., Ma S. Y., Lipton J. W., Tong C. W., Hong J. S., Carvey P. M., In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain Movement Disorders 2002 17 1 116 124 (Pubitemid 36041267)
54. Baldwin A. S. Jr., The NF- B and I B proteins: new discoveries and insights Annual Review of Immunology 1996 14 649 681
55. Baldwin A. S. Jr., Series introduction: the transcription factor NF-kappaB and human disease The Journal of Clinical Investigation 2001 107 1 3 6
56. Boyle E. M. Jr., Kovacich J. C., Hebert C. A., Canty T. G., Chi E., Morgan E. N., Pohlman T. H., Verrier E. D., Fullerton D. A., Starnes V. A., Chaux A., Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury Journal of Thoracic and Cardiovascular Surgery 1998 116 1 114 121 (Pubitemid 28328635)
57. Chandrasekar B., Freeman G. L., Induction of nuclear factor B and activation protein 1 in postischemic myocardium FEBS Letters 1997 401 1 30 34 (Pubitemid 27051252)
58. Jackson-Lewis V., Smeyne R. J., MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview Neurotoxicity Research 2005 7 3 193 201
59. Liu Y., Qin L., Li G., Zhang W., An L., Liu B., Hong J. S., Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation Journal of Pharmacology and Experimental Therapeutics 2003 305 1 212 218 (Pubitemid 36373853)
60. Qian L., Block M. L., Wei S. J., Lin C. F., Reece J., Pang H., Wilson B., Hong J. S., Flood P. M., Interleukin-10 protects lipopolysaccharide-induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase Journal of Pharmacology and Experimental Therapeutics 2006 319 1 44 52 (Pubitemid 44455109)
61. Qian L., Kai S. T., Wei S. J., Wu H. M., Xu Z., Wilson B., Lu R. B., Hong J. S., Flood P. M., Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity Journal of Immunology 2007 179 2 1198 1209
62. Loeffler D. A., DeMaggio A. J., Juneau P. L., Havaich M. K., LeWitt P. A., Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation Clinical Neuropharmacology 1994 17 4 370 379 (Pubitemid 24239388)
63. Sanlioglu S., Williams C. M., Samavati L., Butler N. S., Wang G., McCray P. B., Ritchie T. C., Hunninghake G. W., Zandi E., Engelhardt J. F., Lipopolysaccharide induces rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor- secretion through IKK regulation of NF- B Journal of Biological Chemistry 2001 276 32 30188 30198
64. Neumann H., Control of glial immune function by neurons GLIA 2001 36 2 191 199 (Pubitemid 33055907)
65. Biber K., Neumann H., Inoue K., Boddeke H. W. G. M., Neuronal On and Off signals control microglia Trends in Neurosciences 2007 30 11 596 602
66. Pocock J. M., Kettenmann H., Neurotransmitter receptors on microglia Trends in Neurosciences 2007 30 10 527 535 (Pubitemid 47513237)
67. Barclay A. N., Wright G. J., Brooke G., Brown M. H., CD200 and membrane protein interactions in the control of myeloid cells Trends in Immunology 2002 23 6 285 290 (Pubitemid 34628770)
68. Lyons A., Downer E. J., Crotty S., Nolan Y. M., Mills K. H. G., Lynch M. A., CD200 ligand-receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4 Journal of Neuroscience 2007 27 31 8309 8313 (Pubitemid 47219605)
69. Hoek R. H., Ruuls S. R., Murphy C. A., Wright G. J., Goddard R., Zurawski S. M., Blom B., Homola M. E., Streit W. J., Brown M. H., Barclay A. N., Sedgwick J. D., Down-regulation of the macrophage lineage through interaction with OX2 (CD200) Science 2000 290 5497 1768 1771 (Pubitemid 32004808)
70. Wright G. J., Puklavec M. J., Willis A. C., Hoek R. M., Sedgwick J. D., Brown M. H., Barclay A. N., Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function Immunity 2000 13 2 233 242
71. Wang X. J., Zhang S., Yan Z. Q., Zhao Y. X., Zhou H. Y., Wang Y., Lu G. Q., Zhang J. D., Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK Free Radical Biology and Medicine 2011 50 9 1094 1106
72. Qin L., Liu Y., Wang T., Wei S. J., Block M. L., Wilson B., Liu B., Hong J. S., NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia Journal of Biological Chemistry 2004 279 2 1415 1421 (Pubitemid 38082669)
73. Qian L., Gao X., Pei Z., Wu X., Block M., Wilson B., Hong J. S., Flood P. M., NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation Parkinsonism and Related Disorders 2007 13 supplement 3 S316 S320
74. Kono H., Rusyn I., Uesugi T., Yamashina S., Connor H. D., Dikalova A., Mason R. P., Thurman R. G., Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat American Journal of Physiology 2001 280 5 G1005 G1012
75. Gujral J. S., Hinson J. A., Farhood A., Jaeschke H., NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia American Journal of Physiology 2004 287 1 G243 G252
76. Pawate S., Shen Q., Fan F., Bhat N. R., Redox regulation of glial inflammatory response to lipopolysaccharide and interferon Journal of Neuroscience Research 2004 77 4 540 551 (Pubitemid 39007006)
77. Le Belle J. E., Orozco N. M., Paucar A. A., Saxe J. P., Mottahedeh J., Pyle A. D., Wu H., Kornblum H. I., Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner Cell Stem Cell 2011 8 1 59 71
78. Li Q., Engelhardt J. F., Interleukin-1 induction of NF B is partially regulated by H 2 O 2 -mediated activation of NF B-inducing kinase Journal of Biological Chemistry 2006 281 3 1495 1505
79. Halliwell B., Jenner P., Impaired clearance of oxidised proteins in neurodegenerative diseases Lancet 1998 351 9114 1510 (Pubitemid 28227053)
80. Jenner P., Oxidative mechanisms in nigral cell death in Parkinson's disease Movement Disorders 1998 13 supplement 1 24 34
81. Jenner P., Olanow C. W., Understanding cell death in Parkinson's disease Annals of Neurology 1998 44 3, supplement 1 S72 S84
82. Jomova K., Vondrakova D., Lawson M., Valko M., Metals, oxidative stress and neurodegenerative disorders Molecular and Cellular Biochemistry 2010 345 1-2 91 104
83. Morgan M. J., Liu Z. G., Crosstalk of reactive oxygen species and NF- B signaling Cell Research 2011 21 1 103 115
84. Flood P. M., Qian L., Peterson L. J., Transcriptional factor NF-kappaB as a target for therapy in Parkinson's disease Parkinson's Disease 2011 2011 8
85. Zhong H., May M. J., Jimi E., Ghosh S., The phosphorylation status of nuclear NF- B determines its association with CBP/p300 or HDAC-1 Molecular Cell 2002 9 3 625 636 (Pubitemid 34273792)
86. Jaspers I., Zhang W., Fraser A., Samet J. M., Reed W., Hydrogen peroxide has opposing effects on IKK activity and I B breakdown in airway epithelial cells American Journal of Respiratory Cell and Molecular Biology 2001 24 6 769 777 (Pubitemid 32554616)
87. Jing Y., Yang J., Wang Y., Li H., Chen Y., Hu Q., Shi G., Tang X., Yi J., Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor B are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent Free Radical Biology and Medicine 2006 40 12 2183 2197 (Pubitemid 43903104)
88. Wang Y., Huang X., Cang H., Gao F., Yamamoto T., Osaki T., Yi J., The endogenous reactive oxygen species promote NF- B activation by targeting on activation of NF- B-inducing kinase in oral squamous carcinoma cells Free Radical Research 2007 41 9 963 971 (Pubitemid 47343400)
89. Wang Y., Yang J., Yi J., Redox sensing by proteins: oxidative modifications on cysteines and the consequent events Antioxid Redox Signal 2012 16 7 649 657
90. Zhang F., Qian L., Flood P. M., Shi J. S., Hong J. S., Gao H. M., Inhibition of I B kinase- protects dopamine neurons against lipopolysaccharide- induced neurotoxicity Journal of Pharmacology and Experimental Therapeutics 2010 333 3 822 833
91. Chinta S. J., Andersen J. K., Nitrosylation and nitration of mitochondrial complex i in Parkinson's disease Free Radical Research 2011 45 1 53 58
92. Clementi E., Brown G. C., Feelisch M., Moncada S., Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7631 7636 (Pubitemid 28293304)
93. Isobe C., Abe T., Terayama Y., Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process Neuroscience Letters 2010 469 1 159 163
94. Isobe C., Abe T., Kikuchi T., Murata T., Sato C., Terayama Y., Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease European Journal of Neurology 2006 13 4 346 350
95. Toms-Camardiel M., Rite I., Herrera A. J., De Pablos R. M., Cano J., Machado A., Venero J. L., Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system Neurobiology of Disease 2004 16 1 190 201 (Pubitemid 38569810)
96. Beal M. F., Oxidatively modified proteins in aging and disease Free Radical Biology and Medicine 2002 32 9 797 803 (Pubitemid 34439250)
97. Kurkowska-Jastrzebska I., Wroska A., Kohutnicka M. S., Czlonkowski A., Czlonkowska A., The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine intoxication in mouse Experimental Neurology 1999 156 1 50 61 (Pubitemid 29152982)
98. Castao A., Herrera A. J., Cano J., Machado A., The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF- IL-1 IFN- Journal of Neurochemistry 2002 81 1 150 157 (Pubitemid 34808862)
99. Sairam K., Saravanan K. S., Banerjee R., Mohanakumar K. P., Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats Brain Research 2003 966 2 245 252 (Pubitemid 36255587)
100. Zhang F., Qian L., Flood P. M., Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity Journal of Pharmacology and Experimental Therapeutics 2010 333 3 822 833
101. Bernardo A., Gasparini L., Ongini E., Minghetti L., Dynamic regulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216: implications for chronic treatments of neurodegenerative diseases Neurobiology of Disease 2006 22 1 25 32
102. Bernardo A., Ajmone-Cat M. A., Gasparini L., Ongini E., Minghetti L., Nuclear receptor peroxisome proliferator-activated receptor- is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen Journal of Neurochemistry 2005 92 4 895 903 (Pubitemid 40229562)
103. Strle K., Zhou J. H., Shen W. H., Broussard S. R., Johnson R. W., Freund G. G., Dantzer R., Kelley K. W., Interleukin-10 in the brain Critical Reviews in Immunology 2001 21 5 427 449 (Pubitemid 34259914)
104. Moore K. W., De Waal Malefyt R., Coffman R. L., O'Garra A., Interleukin-10 and the interleukin-10 receptor Annual Review of Immunology 2001 19 683 765 (Pubitemid 32368050)
105. Johnston L. C., Su X., Maguire-Zeiss K., Horovitz K., Ankoudinova I., Guschin D., Hadaczek P., Federoff H. J., Bankiewicz K., Forsayeth J. R., Human interleukin-10 gene transfer is protective in a rat model of parkinson's disease Molecular Therapy 2008 16 8 1392 1399
106. Zhu Y., Yang G. Y., Ahlemeyer B., Pang L., Che X. M., Culmsee C., Klumpp S., Krieglstein J., Transforming growth factor- 1 increases bad phosphorylation and protects neurons against damage Journal of Neuroscience 2002 22 10 3898 3909 (Pubitemid 37465698)
107. Prehn J. H., Krieglstein J., Opposing effects of transforming growth factor- 1 on glutamate neurotoxicity Neuroscience 1994 60 1 7 10 (Pubitemid 24147602)
108. Qian L., Wei S. J., Zhang D., Hu X., Xu Z., Wilson B., El-Benna J., Hong J. S., Flood P. M., Potent anti-inflammatory and neuroprotective effects of tgf- 1 are mediated through the inhibition of erk and p47phox-Ser345 phosphorylation and translocation in microglia Journal of Immunology 2008 181 1 660 668
109. Zhang W., Wang T., Qin L., Gao H. M., Wilson B., Ali S. F., Zhang W., Hong J. S., Liu B., Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase The FASEB Journal Biology 2004 18 3 589 591
110. Zhang W., Qin L., Wang T., Wei S. J., Gao H. M., Liu J., Wilson B., Liu B., Zhang W., Kim H. C., Hong J. S., 3-Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity The FASEB Journal 2005 19 3 395 397 (Pubitemid 40316528)
111. Zhang W., Shin E. J., Wang T., Phil H. L., Pang H., Wie M. B., Kim W. K., Kim S. J., Huang W. H., Wang Y., Zhang W., Hong J. S., Kim H. C., 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro The FASEB Journal 2006 20 14 2496 2511 (Pubitemid 44953822)
112. Liu L., Resch K., Kaever V., Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine International Journal of Immunopharmacology 1994 16 8 685 691 (Pubitemid 24238693)
113. Liu L., Buchner E., Beitze D., Schmidt-Weber C. B., Kaever V., Emmrich F., Kinne R. W., Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine International Journal of Immunopharmacology 1996 18 10 529 543 (Pubitemid 27105916)
114. Koff W. C., Fann A. V., Dunegan M. A., Lachman L. B., Catecholamine-induced suppression of interleukin-1 production Lymphokine Research 1986 5 4 239 247 (Pubitemid 17203711)
115. van der Poll T., Jansen J., Endert E., Sauerwein H. P., Van Deventer S. J. H., Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood Infection and Immunity 1994 62 5 2046 2050 (Pubitemid 24137012)
116. Sekut L., Champion B. R., Page K., Menius J. A., Connolly K. M., Anti-inflammatory activity of salmeterol: down-regulation of cytokine production Clinical and Experimental Immunology 1995 99 3 461 466
117. Severn A., Rapson N. T., Hunter C. A., Liew F. Y., Regulation of tumor necrosis factor production by adrenaline and -adrenergic agonists Journal of Immunology 1992 148 11 3441 3445
118. Farmer P., Pugin J., beta-adrenergic agonists exert their anti-inflammatory effects in monocytic cells through the IkappaB/NF-kappaB pathway American Journal of Physiology 2000 279 4 L675 L682
119. Kin N. W., Sanders V. M., It takes nerve to tell T and B cells what to do Journal of Leukocyte Biology 2006 79 6 1093 1104 (Pubitemid 44835542)
120. Panina-Bordignon P., Mazzeo D., Lucia P. D., Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12 The Journal of Clinical Investigation 1997 100 6 1513 1519 (Pubitemid 27425778)
121. Qian L., Wu H. M., Chen S. H., {beta}2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway The Journal of Immunology 2011 186 7 4443 4454
122. Tan K. S., Nackley A. G., Satterfield K., Maixner W., Diatchenko L., Flood P. M., Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms Cellular Signalling 2007 19 2 251 260 (Pubitemid 46017083)
123. Maguire-Zeiss K. A., Short D. W., Federoff H. J., Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Molecular Brain Research 2005 134 1 18 23 (Pubitemid 40409494)
124. Gandhi S., Wood N. W., Molecular pathogenesis of Parkinson's disease Human Molecular Genetics 2005 14 18 2749 2755 (Pubitemid 41300647)
125. Graham D. G., Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Molecular Pharmacology 1978 14 4 633 643 (Pubitemid 8402469)
126. Basma A. N., Morris E. J., Nicklas W. J., Geller H. M., L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation Journal of Neurochemistry 1995 64 2 825 832
127. Jin C. M., Yang Y. J., Huang H. S., Kai M., Lee M. K., Mechanisms of L-DOPA-induced cytotoxicity in rat adrenal pheochromocytoma cells: implication of oxidative stress-related kinases and cyclic AMP Neuroscience 2010 170 2 390 398
128. Sabens Liedhegner E. A., Steller K. M., Mieyal J. J., Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease Chemical Research in Toxicology 2011 24 10 1644 1652
129. Buhmann C., Arlt S., Kontush A., Mller-Bertram T., Sperber S., Oechsner M., Stuerenburg H. J., Beisiegel U., Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication Neurobiology of Disease 2004 15 1 160 170 (Pubitemid 38134391)
130. Prigione A., Begni B., Galbussera A., Beretta S., Brighina L., Garofalo R., Andreoni S., Piolti R., Ferrarese C., Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage Neurobiology of Disease 2006 23 1 36 43 (Pubitemid 43903629)